Facebook Linkedin Youtube X-twitter Instagram
Professional Syndicates Complex, Sharif Abdel Hamid Sharaf Street, 31, Amman, Jordan
About Jordan
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
    • Scientific materials 2
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
Login
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
    • Scientific materials 2
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
  • من نحن
    • تاريخ الجمعية
    • هيكل الجمعية
    • ادارة الجمعية
    • تطوع معنا
  • العضوية
    • طلب انتساب
    • الاعضاء المنتسبون
    • Types of memberships in the Society of Cardiologists
  • Home
  • نشاطات
  • مواد علمية
  • Health Education
  • جاليري
    • فيديو
    • صور
  • اتصل بنا
Uncategorized
webadmin April 3, 2025 0

The Role of Maintaining Lower LDL-C Level During Statin Treatment for Advanced CKD Patients

 “The Role of Maintaining Lower LDL-C Level During Statin Treatment for Advanced CKD Patients”
Summary of the Study:
1. Background
• A previous study in Taiwanese patients with stage 3 CKD showed that lowering LDL-c to <70 mg/dL or 70–99 mg/dL reduced the risk of major adverse cardiac and cerebrovascular events (MACCE) and new-onset end-stage renal disease (ESRD) compared to LDL-c ≥100 mg/dL.
• This study aimed to determine if similar benefits apply to patients with advanced CKD (stage 4–5).
• No direct evidence from randomized controlled trials (RCTs) currently supports specific LDL-C targets for different CKD stages.
• The impact of LDL-C lowering on cardiovascular and renal outcomes in advanced CKD (stage 4–5) remains unclear.
• This cohort study suggests that statin users with LDL-C <70 mg/dL have relatively favorable 5-year cardiovascular (CV) and renal outcomes in advanced CKD patients.
• Lower LDL-C levels may be beneficial for CV protection as CKD progresses, but further RCTs are needed.
2. Study Aim
• To investigate whether maintaining a lower LDL-C level during statin treatment benefits patients with advanced CKD in terms of cardiovascular and renal outcomes.
3. Methods
• Observational cohort study using data from patients with stage 4 CKD.
• Patients categorized based on post-treatment LDL-C levels.
• Outcomes compared between different LDL-C level groups.
4. Key Findings
• Lower LDL-C levels (<70 mg/dL) were associated with:
• Reduced cardiovascular risks, including MACCE and CV death.
• Lower incidence of new-onset ESRD requiring dialysis.
• No significant benefits observed for LDL-C levels between 70–99 mg/dL.
• No randomized trials confirm these findings, highlighting the need for further prospective studies.
5. Conclusion
• The study suggests that maintaining LDL-C <70 mg/dL in statin-treated advanced CKD patients may provide cardiovascular and renal protection.
• However, further RCTs are warranted to confirm these results.
https://www.atherosclerosis-journal.com/article/S0021-9150(24)01214-0/fulltext
554 Views
38
The Role of Icosapent Ethyl in Cardiovascular Risk Reduction. Highlighted by AHAApril 3, 2025
Plant-Based Diets and Longevity in Patients with Cardiometabolic DisordersApril 3, 2025

مقالات ذات صلة

Uncategorized

Article summary : “Waist-to-Height Ratio Predicts Heart Risk at Age 10 Years”

webadmin May 22, 2025
Uncategorized

New Ideas in Cardiology — March 2026 (ACC Conference Coverage Highlights)

jordan heart March 28, 2026

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

احدث المقالات

  • HRS 2026 VT Ablation: Recent Breakthroughs
  • 2026 ACC Scientific Statement: DOAC Therapy
  • The Jordan Cardiac Society (JCS) shares the following joint statement regarding the postponement of the ACC Middle East 2026 Together With JCS Annual Meeting.
  • Ross Procedure Emerges as a New Gold Standard for Young Patients Requiring Aortic Valve Replacement
  • Guideline-Directed Medical Therapy (GDMT) for HFrEF: The Four Pillars

فئات

  • Health Education
  • Previous lectures and conferences
  • Uncategorized

Jordanian Cardiology Society

Jordanian Cardiology Society

Amman-Jordan

00962795001983

Working hours

From Sunday to Thursday

From nine in the morning until four in the afternoon

Important Links

Jordanian Cardiology Society

Research and studies

Medical articles

Login

Privacy Policy

Refund Policy

Cancellation Policy

Delivery Policy

Association Location

Copyright © 2024 Jordanian Cardiologists Association by WebAppRoots. All Rights Reserved.